Lot numbers appear on both individual vials and the box, and begin with alpha numeric codes such as L1, K1 or H1.

The packaging and/or vials.

Proof of purchase between March 2014 and October 2015.

Any documented evidence of your out-of-pocket expenses, such as receipts or bank statements that may highlight the drug.

Any documents concerning your treatments / procedures.

Any documents concerning your fertility treatments and medical procedures for which was prescribed, including all documents evidencing your out-of-pocket expenses.

About The Allergan Biocell Textured Breast Implants Case:

This lawsuit comes in the wake of the FDA's request that Allergan issue a recall of its Biocell textured breast implants and tissue expanders. Allergan agreed and is removing these products from the global market. The FDA requested the recall based on newly submitted Medical Device Reports reporting worldwide cases of BIA-ALCL and BIA-ALCL-related deaths associated with these implants.

First Name *

Last Name *

Address 1 *

Address 2

City *

Your State *

ZIP Code *

Phone Number *

Email *

Are you a current or former employee? *

How many Solana Labs Inc. shares did you purchase? *

What date(s) did you purchase the shares? *

What was the price per share when you purchased them? *

How many Solana Labs Inc. shares did you sell? *

What date(s) did you sell the shares? *

What was the price per share when you sold them? *

I have not sought to serve, or served, as a representative party on behalf of a class under the federal securities laws during the last three years, except as detailed here.

I declare under penalty of perjury that the foregoing are true and correct statements. *

Yes

*Required Fields

This is attorney advertising. Past results cannot be an assurance of future success in any given case, because each matter must be decided on its own merits.

Click Here to Read the Class Action Complaint

To speak with us on a confidential basis about your Allergan Biocell implants, or to learn how you can join the class action, please complete the contact form below. Your consultation with our law firm will be free of charge.

The typical things needed to move forward:

aabramowitz@bm.net

(215) 875-3015

bergermontague.com

Berger Montague
1818 Market Street, Suite 3600
Philadelphia, PA 19103

Andrew Abramowitz, Esq.

Counsel Information:

Berger Montague Investigates Securities Violations Against Solana Labs, Inc. and the
Solana Foundation; Lead Plaintiff Deadline is September 6, 2022.

Join the class action against Solana Labs Inc.:

Berger Montague has filed a nationwide class action lawsuit against medical device manufacturer Allergan to protect women from the harmful Biocell Textured Breast Implant. The case is Alabama Doe, et al. v. Allergan, Inc., et al.

On July 24, 2019, Allergan announced a recall of certain Biocell textured breast implants after reports showed a possible link between the implants and a type of non-Hodgkin's lymphoma (cancer of the immune system).

Our class action claims the recall doesn't fully compensate proposed class members for the costs of replacing or retaining their implants and aims to force Allergan to pay for the costs of surgery, diagnostic testing, and medical monitoring in people who have Biocell implants.

Double-click to edit this text

Michael Dell’Angelo, Esq.

mdellangelo@bm.net

(215) 875-3080

bergermontague.com

Berger Montague
1818 Market Street, Suite 3600
Philadelphia, PA 19103

About the Solana Labs Inc. Class Action:

Headquartered in San Francisco, Solana Labs, Inc., is a blockchain network and cryptocurrency operator. Solana Labs began issuing and offering $SOL cryptocurrency to U.S. investors on or about March 24, 2020.

According to a lawsuit recently filed in the United States District Court for the Northern District of California, Solana Labs and its co-defendants issued and sold $SOL without registering the tokens with the U.S. Securities and Exchange Commission (SEC) as required under the federal securities laws . The suit alleges that throughout the Class Period, Solana Labs and its co-defendants promoted and sold unregistered $SOL securities to investors, and that such investors have suffered losses as a consequence of the Defendants’ misrepresentations and omissions.